Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « Masayuki Miyata »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masayuki Miyagi < Masayuki Miyata < Masayuki Nishide  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000879 (2019) Wataru Fukuda ; Tadamasa Hanyu ; Masaki Katayama ; Shinichi Mizuki ; Akitomo Okada ; Masayuki Miyata ; Yuichi Handa ; Masatoshi Hayashi ; Yoshinobu Koyama ; Kaoru Arii ; Toshiyuki Kitaori ; Hiroyuki Hagiyama ; Yoshinori Urushidani ; Takahito Yamasaki ; Yoshihiko Ikeno ; Takeshi Suzuki ; Atsushi Omoto ; Toshifumi Sugitani ; Satoshi Morita ; Shigeko InokumaRisk stratification and clinical course of hepatitis B virus reactivation in rheumatoid arthritis patients with resolved infection: final report of a multicenter prospective observational study at Japanese Red Cross Hospital
000965 (2019) Masaru Kato [Japon] ; Yuko Kaneko [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Isao Yokota [Japon] ; Tatsuya Atsumi [Japon] ; Tsutomu Takeuchi [Japon]Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study.
001140 (2018) Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
001C25 (2016) Yuko Kaneko [Japon] ; Tatsuya Atsumi [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekata Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Hayato Nagasawa [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
001C36 (2016) Yasuhiko Hirabayashi [Japon] ; Yasuhiko Munakata [Japon] ; Masayuki Miyata [Japon] ; Yukitomo Urata [Japon] ; Koichi Saito [Japon] ; Hiroshi Okuno [Japon] ; Masaaki Yoshida [Japon] ; Takao Kodera [Japon] ; Ryu Watanabe [Japon] ; Seiya Miyamoto [Japon] ; Tomonori Ishii [Japon] ; Shigeshi Nakazawa [Japon] ; Hiromitsu Takemori [Japon] ; Takanobu Ando [Japon] ; Takashi Kanno [Japon] ; Masataka Komagamine [Japon] ; Ichiro Kato [Japon] ; Yuichi Takahashi [Japon] ; Atsushi Komatsuda [Japon] ; Kojiro Endo [Japon] ; Chihiro Murai [Japon] ; Yuya Takakubo [Japon] ; Takao Miura [Japon] ; Yukio Sato [Japon] ; Kazunobu Ichikawa [Japon] ; Tsuneo Konta [Japon] ; Noriyuki Chiba [Japon] ; Tai Muryoi [Japon] ; Hiroko Kobayashi [Japon] ; Hiroshi Fujii [Japon] ; Yukio Sekiguchi [Japon] ; Akira Hatakeyama [Japon] ; Ken Ogura [Japon] ; Hirotake Sakuraba [Japon] ; Tomoyuki Asano [Japon] ; Hiroshi Kanazawa [Japon] ; Eiji Suzuki [Japon] ; Satoshi Takasaki [Japon] ; Kenichi Asakura [Japon] ; Kota Sugisaki [Japon] ; Yoko Suzuki [Japon] ; Michiaki Takagi [Japon] ; Takahiro Nakayama ; Hiroshi Watanabe [Japon] ; Keiki Miura [Japon] ; Yu Mori [Japon]Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "Masayuki Miyata" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "Masayuki Miyata" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    Masayuki Miyata
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021